|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Celgene_Corporation
gptkb:NantKwest
gptkb:Zymeworks
gptkb:Immunomedics
gptkb:Juno_Therapeutics
gptkb:Flexus_Biosciences
gptkb:Myokardia
gptkb:Celerion
AstraZeneca's_diabetes_business
|
|
gptkbp:CEO
|
Giovanni Caforio
|
|
gptkbp:divisions
|
Finance
Human Resources
Information Technology
Manufacturing
Business Development
Global Supply Chain
Legal
Commercial Operations
Corporate Affairs
Research_and_Development
|
|
gptkbp:employees
|
30,000+
|
|
gptkbp:founded
|
1887
|
|
gptkbp:founder
|
gptkb:William_McLaren_Bristol
gptkb:John_Ripley_Myers
|
|
gptkbp:headquarters
|
gptkb:New_York_City
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bristol-Myers Squibb Company, LLC
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:Lamberto_Andreotti
gptkb:Charles_Bancroft
Giovanni Caforio
|
|
gptkbp:products
|
gptkb:Opdivo
Reblozyl
Eliquis
Yervoy
|
|
gptkbp:revenue
|
$46.4 billion (2020)
|
|
gptkbp:sells
|
NYSE: BMY
|
|
gptkbp:subsidiary
|
gptkb:Bristol-Myers_Squibb_Foundation
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.bms.com
|